Compare ANIP & NWN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ANIP | NWN |
|---|---|---|
| Founded | 2001 | 1859 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil/Gas Transmission |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 1999 | 2018 |
| Metric | ANIP | NWN |
|---|---|---|
| Price | $85.19 | $49.82 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 3 |
| Target Price | ★ $110.00 | $54.33 |
| AVG Volume (30 Days) | ★ 291.4K | 280.5K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 3.71% |
| EPS Growth | ★ 419.23 | 36.45 |
| EPS | 1.28 | ★ 2.33 |
| Revenue | $206,547,000.00 | ★ $1,289,363,000.00 |
| Revenue This Year | $21.01 | $11.37 |
| Revenue Next Year | $17.59 | $4.46 |
| P/E Ratio | $66.23 | ★ $21.31 |
| Revenue Growth | 2.47 | ★ 11.83 |
| 52 Week Low | $62.61 | $39.29 |
| 52 Week High | $99.50 | $55.99 |
| Indicator | ANIP | NWN |
|---|---|---|
| Relative Strength Index (RSI) | 58.25 | 51.17 |
| Support Level | $77.16 | $48.32 |
| Resistance Level | $87.42 | $50.17 |
| Average True Range (ATR) | 2.60 | 1.11 |
| MACD | 0.28 | 0.05 |
| Stochastic Oscillator | 75.84 | 46.54 |
ANI Pharmaceuticals Inc is a diversified biopharmaceutical company. It is focused on developing, manufacturing, and commercializing therapeutics through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; and through its Generics and Brands businesses. The firm's product portfolio comprises Purified Cortrophin Gel, ILUVIEN, and YUTIQ (fluocinolone acetonide intravitreal implant), among others. Additionally, its Generics portfolio includes several products with a wide variety of indications. The company has two operating segments: Rare Disease and Brands, which derive maximum revenue, and Generics and Other. Geographically, it generates maximum revenue from the United States, followed by other markets.
Northwest Natural Holding Co is a public natural gas service supplier operating in the U.S. Pacific Northwest. Its subsidiary, NW Natural, operates through the natural gas distribution segment, which purchases and distributes natural gas through which operates in Oregon and southwest Washington. The company operates in three reportable business segments, which are NWN Gas Utility, SiEnergy, and NWN Water. The company generates maximum revenue from NWN Gas Utility segment. It also generates revenue from residential, commercial, and industrial customers, the majority of which are in Oregon. Residential and commercial customers account for the vast majority of profitability.